WHO linked the syrups made by India's Maiden Pharmaceuticals to the deaths of 70 children in 2022, though govt stated that subsequent lab tests showed the syrups were not toxic.
The CDSCO has also proposed making it mandatory for exporters to produce a 'certificate of analysis' of batches exported from an approved laboratory, the news outlet reported.
The Centre's statement comes weeks after the WHO alerted that the firm’s cough syrups could potentially be linked to the death of 66 children in Gambia.
Nearly 70 children had died from the same illness in Gambia after taking a paracetamol syrup. The WHO had 'potentially' linked their deaths to cough syrups manufactured in India.
Haryana health minister said the government has sent cough syrup samples to central pharmaceutical laboratory for testing after deaths of 66 children in the West African country.
Following the transaction which is expected to be completed by November, Dassault Reliance Aerospace Ltd will become an associate company, with Reliance retaining a 49% stake.
From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.
COMMENTS